Sharma et al. found that while the non-small cell lung cancer (NSCLC)-derived cell line PC9 is sensitive to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs), a small fraction of PC9 cells are tolerant to EGFR TKIs [87]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.